Join Now
Join over 8222 active members:
 
CMTA Newswire

CMTA Expands Preclinical Testing for Hereditary Neuropathy Therapies

CMTA and STAR The Charcot-Marie-Tooth Association (CMTA), a registered 501c3 serving the hereditary neuropathy patient community, announced that it has formalized a preclinical testing program that employs laboratory models of Charcot-Marie-Tooth (CMT) disorders to evaluate candidate therapeutics.

The Foundation has acquired rights to a laboratory model overexpressing the Peripheral Myelin Protein-22 (PMP22) gene, for use in its program, from the Max Planck Institute for Experimental Medicine in Göttingen, Germany (http://www.em.mpg.de). An agreement to use a laboratory model overexpressing the human PMP22 gene...

Read more...
 

Add a Little Bling to Your Spring!

Join or Start a Support and Action Group
& Get a Limited Edition CMTA Pin!

CMTA Pin

Dear...

Read more...
 

The March-April 2014 CMTA Report

The March-April, 2014, CMTA Report PDF is now available.

In addition to our regular features, you'll find these articles and items of...

Read more...
 

Open House: Meet CMT Experts at Cedars-Sinai

Cedars-Sinai Medical Pavilion In conjunction with the CMTA, Drs. Richard Lewis, Robert Baloh, Glenn Pfeffer and their team of CMT experts are hosting a “Meet and Greet” at Cedars-Sinai...

Read more...
 

CMTA Youth Outing in Los Angeles

It's time to celebrate being young, so members of the CMTA have planned an evening of fun for teens between the ages of 13 and 19. Leading the event are CMTA volunteer Yohan Bouchard and Advisory Board Members

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 5 of 35

CMTA Newswire